Literature DB >> 9950255

Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.

L L Loro1, O K Vintermyr, A C Johannessen, P G Liavaag, R Jonsson.   

Abstract

Apoptosis and the expression of Fas receptor (Fas) and Fas ligand (FasL) were studied in 8 samples of normal oral mucosa (OM) and in 19 oral squamous cell carcinomas (OSCC) by immunohistochemistry and the TUNEL method. Fas was detected in less than 2% of cells in OSCC compared with 84.3+/-9.0% of cells in the basal layer in OM. FasL was found to be highly expressed in poorly differentiated lesions (90.9+/-3.6%), and in cells of both the basal (88.3+/-4.3%) and central (85.3+/-5.7%) parts of moderately differentiated lesions, whereas in well-differentiated (WD) lesions expression was considerably lower in both basal (42.7+/-4.1%) and central (11.5+/-2.4%) parts. In normal OM FasL was primarily detected in cells of the basal layer, but in a high proportion of cells (84.9+/-4.3%). Apoptotic cell death was greater in OSCC (1.6+/-0.6%) than in OM (0.6+/-0.2%, P<0.05) and was most pronounced in the central part of WD OSCC (2.3+/-0.5%). Our results show that Fas is expressed in low quantities in OSCC and that FasL expression correlates negatively with degree of differentiation and apoptosis in OSCC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950255     DOI: 10.1111/j.1600-0714.1999.tb02001.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

Review 1.  Anoikis mediators in oral squamous cell carcinoma.

Authors:  J Bunek; P Kamarajan; Y L Kapila
Journal:  Oral Dis       Date:  2010-11-29       Impact factor: 3.511

Review 2.  Molecular pathogenesis of oral squamous carcinoma.

Authors:  H K Williams
Journal:  Mol Pathol       Date:  2000-08

Review 3.  How patients with an intact immune system develop head and neck cancer.

Authors:  Sarah Greene; Priya Patel; Clint T Allen
Journal:  Oral Oncol       Date:  2019-03-18       Impact factor: 5.337

4.  Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

5.  The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.

Authors:  Y Ito; M Monden; T Takeda; H Eguchi; K Umeshita; H Nagano; S Nakamori; K Dono; M Sakon; M Nakamura; M Tsujimoto; M Nakahara; K Nakao; Y Yokosaki; N Matsuura
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

Review 6.  Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma.

Authors:  Steven He; Rajdeep Chakraborty; Shoba Ranganathan
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

7.  Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells.

Authors:  A Trauzold; S Schmiedel; C Röder; C Tams; M Christgen; S Oestern; A Arlt; S Westphal; M Kapischke; H Ungefroren; H Kalthoff
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.